These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 25903129)
1. Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling. Cheng YH; Ho MS; Huang WT; Chou YT; King K J Biol Chem; 2015 Jun; 290(23):14302-13. PubMed ID: 25903129 [TBL] [Abstract][Full Text] [Related]
2. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice. Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410 [TBL] [Abstract][Full Text] [Related]
3. Isolation of Positive Modulator of Glucagon-like Peptide-1 Signaling from Trigonella foenum-graecum (Fenugreek) Seed. King K; Lin NP; Cheng YH; Chen GH; Chein RJ J Biol Chem; 2015 Oct; 290(43):26235-48. PubMed ID: 26336108 [TBL] [Abstract][Full Text] [Related]
4. Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor. Li N; Lu J; Willars GB PLoS One; 2012; 7(10):e47936. PubMed ID: 23094100 [TBL] [Abstract][Full Text] [Related]
5. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053 [TBL] [Abstract][Full Text] [Related]
6. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Lauffer LM; Iakoubov R; Brubaker PL Diabetes; 2009 May; 58(5):1058-66. PubMed ID: 19208912 [TBL] [Abstract][Full Text] [Related]
7. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide. Nakane A; Gotoh Y; Ichihara J; Nagata H Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912 [TBL] [Abstract][Full Text] [Related]
8. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation. Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM J Biol Chem; 2012 Feb; 287(6):3642-58. PubMed ID: 22147710 [TBL] [Abstract][Full Text] [Related]
9. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery. Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467 [TBL] [Abstract][Full Text] [Related]
10. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Baggio LL; Huang Q; Brown TJ; Drucker DJ Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587 [TBL] [Abstract][Full Text] [Related]
11. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Baggio LL; Huang Q; Brown TJ; Drucker DJ Diabetes; 2004 Sep; 53(9):2492-500. PubMed ID: 15331566 [TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor. Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966 [TBL] [Abstract][Full Text] [Related]
13. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor. Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452 [TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207 [TBL] [Abstract][Full Text] [Related]
19. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Wheeler MB; Lu M; Dillon JS; Leng XH; Chen C; Boyd AE Endocrinology; 1993 Jul; 133(1):57-62. PubMed ID: 8391428 [TBL] [Abstract][Full Text] [Related]
20. Regulation of GPR119 receptor activity with endocannabinoid-like lipids. Syed SK; Bui HH; Beavers LS; Farb TB; Ficorilli J; Chesterfield AK; Kuo MS; Bokvist K; Barrett DG; Efanov AM Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1469-78. PubMed ID: 23074242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]